Acrobiosystems Co.,Ltd. (SHE:301080)

China flag China · Delayed Price · Currency is CNY
39.67
-0.41 (-1.02%)
At close: Jun 2, 2026
Market Cap6.63B +15.6%
Revenue (ttm)887.21M +29.4%
Net Income171.25M +28.0%
EPS1.04 +32.4%
Shares Out 167.18M
PE Ratio38.18
Forward PE22.93
Dividend0.60 (1.50%)
Ex-Dividend Daten/a
Volume1,893,130
Open39.99
Previous Close40.08
Day's Range39.16 - 40.08
52-Week Range36.99 - 71.49
Beta0.76
AnalystsStrong Buy
Price Target72.71 (+83.29%)
Earnings DateAug 21, 2026

About Acrobiosystems

Acrobiosystems Co.,Ltd. engages in the development and manufacture of recombinant proteins, antibodies, and other biological reagents for pharmaceutical and biotechnology companies, and scientific research institutions. The company has a collaboration with Diagnostic Biochips Inc for neurological drug discovery and commercialization. The company was founded in 2010 and is based in Beijing, China. [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2010
Employees 926
Stock Exchange Shenzhen Stock Exchange
Ticker Symbol 301080
Full Company Profile

Financial Performance

In 2025, Acrobiosystems's revenue was 838.12 million, an increase of 29.94% compared to the previous year's 645.02 million. Earnings were 165.57 million, an increase of 33.70%.

Financial Statements